Eloxx Pharmaceuticals, Inc.
Public company- Headquarters
- ARLINGTON, Massachusetts
- Industry
- Biotechnology
- Ticker
- ELOX
- CIK
- 0001035354
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
1 appointment, 0 departures
Last event
Oct 22, 2026
Executive appointmentdirector appointed: Geno J. Germano
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| directorGeno J. Germano | Oct 22, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- Voyager Therapeutics, Inc.
president appointed: Robin Swartz
- TScan Therapeutics, Inc.
Director departs: Garry Nicholson
- Moderna, Inc.
COO appointed: Juan Andres
- REPLIGEN CORP
Board of Directors departs: Karen A. Dawes
- Executive appointment
director appointed: Geno J. Germano
Geno J. Germano was named director of Eloxx Pharmaceuticals, Inc., effective October 19, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 22, 2026Role: director
Only one public record so far. We add events as soon as a new filing lands; watch Eloxx Pharmaceuticals, Inc. to get them in your digest.
Last verified Nov 8, 2026